Cargando…
Toxicity Study of 28-Day Subcutaneous Injection of Arctigenin in Beagle Dogs
Our previous studies have investigated the systematic pharmacokinetic characteristics, biological activities, and toxicity of arctigenin. In this research, the potential toxicities of arctigenin in beagle dogs were investigated via repeated 28-day subcutaneous injections. Beagle dogs were randomly d...
Autores principales: | Li, Jie, Lv, Yun-gang, Pan, Li-hong, Yao, Fang-fang, Peng, Tao, Tan, Yu-jun, Zhang, Gui-Min, Liu, Zhong, Yao, Jing-chun, Ren, Yu-shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807677/ https://www.ncbi.nlm.nih.gov/pubmed/31680982 http://dx.doi.org/10.3389/fphar.2019.01218 |
Ejemplares similares
-
28-Day Oral Chronic Toxicity Study of Arctigenin in Rats
por: Tan, Yu-jun, et al.
Publicado: (2018) -
Elucidation of Arctigenin Pharmacokinetics and Tissue Distribution after Intravenous, Oral, Hypodermic and Sublingual Administration in Rats and Beagle Dogs: Integration of In Vitro and In Vivo Findings
por: Li, Jie, et al.
Publicado: (2017) -
Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα
por: Sun, Ying, et al.
Publicado: (2018) -
GMP-grade α-TEA lysine salt: a 28-Day oral toxicity and toxicokinetic study with a 28-Day recovery period in Beagle dogs
por: Guerrouahen, Bella S., et al.
Publicado: (2016) -
Comparison of pain response after subcutaneous injection of two maropitant formulations to beagle dogs
por: Deckers, Nynke, et al.
Publicado: (2018)